SC
WST icon

Settian Capital’s West Pharmaceutical WST Stock Holding History

Settian Capital’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-6,100
Closed -$1.37M – 27
2025
Q1 		$1.37M Hold
6,100
– – 1.06% 23
2024
Q4 		$2M Hold
6,100
– – 1.44% 19
2024
Q3 		$1.83M Hold
6,100
– – 1.33% 21
2024
Q2 		$2.01M Hold
6,100
– – 1.47% 21
2024
Q1 		$2.41M Hold
6,100
– – 1.79% 16
2023
Q4 		$2.15M Hold
6,100
– – 1.71% 18
2023
Q3 		$2.29M Hold
6,100
– – 1.94% 16
2023
Q2 		$2.33M Buy
+6,100
New +$2.18M 1.95% 12
2023
Q1 		– Sell
-6,100
Closed -$1.44M – 36
2022
Q4 		$1.44M Buy
6,100
+600
+11% +$142K 1.26% 30
2022
Q3 		$1.35M Hold
5,500
– – 1.48% 27
2022
Q2 		$1.66M Hold
5,500
– – 2.61% 12
2022
Q1 		$2.26M Hold
5,500
– – 2.18% 17
2021
Q4 		$2.58M Buy
+5,500
New +$2.37M 2.23% 15

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

Settian Capital's WST Position: Q2 2025 in Review

Settian Capital sold out of West Pharmaceutical (WST) in Q2 2025, closing a stake of 6,100 shares — an estimated $1.37M sold.

Settian Capital first reported a position in WST in Q4 2021 and held it in 13 quarters. The position peaked at $2.58M in Q4 2021. 731 funds tracked by Wall St. Rank hold WST as of Q2 2025.

  • Settian Capital reported no remaining West Pharmaceutical position as of Q2 2025 after selling out during the quarter.
  • Settian Capital sold 6,100 West Pharmaceutical shares in Q2 2025, an estimated $1.37M.
  • Settian Capital first reported a position in West Pharmaceutical in Q4 2021 and held it in 13 quarters.
  • Settian Capital's West Pharmaceutical position peaked at $2.58M in Q4 2021.
  • 731 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2025.

Based on Settian Capital's 13F filing for Q2 2025, filed 6 Aug 2025.